C
Chiun-Sheng Huang
Researcher at National Taiwan University
Publications - 275
Citations - 11035
Chiun-Sheng Huang is an academic researcher from National Taiwan University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 46, co-authored 241 publications receiving 8825 citations. Previous affiliations of Chiun-Sheng Huang include Academia Sinica & Taipei Medical University.
Papers
More filters
Journal ArticleDOI
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
Giuseppe Curigliano,Harold J. Burstein,Eric P. Winer,Michael Gnant,Peter Dubsky,Sibylle Loibl,Marco Colleoni,Meredith M. Regan,Martine Piccart-Gebhart,H.-J. Senn,Beat Thürlimann,Fabrice Andre,José Baselga,Jonas Bergh,Hervé Bonnefoi,Sara Y. Brucker,Fatima Cardoso,Lisa A. Carey,Eva Ciruelos,Jack Cuzick,Carsten Denkert,A. Di Leo,Bent Ejlertsen,Prudence A. Francis,Viviana Galimberti,Judy Garber,Bahadir M. Gulluoglu,Pamela J. Goodwin,Nadia Harbeck,Daniel F. Hayes,Chiun-Sheng Huang,Jens Huober,H. Khaled,Jacek Jassem,Zefei Jiang,Per Karlsson,Monica Morrow,Roberto Orecchia,Kent Osborne,Olivia Pagani,Ann H. Partridge,Kathleen I. Pritchard,Jungsil Ro,Emiel J. Th. Rutgers,Felix Sedlmayer,Vladimir Semiglazov,Zhimin Shao,I.E. Smith,Masakazu Toi,Andrew Tutt,Giuseppe Viale,Toshihiro Watanabe,Timothy J. Whelan,Bo Xu +53 more
TL;DR: The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna, Austria reviewed substantial new evidence on loco-regional and systemic therapies for early breast cancer, and recommended bisphosphonate use in postmenopausal women to prevent breast cancer recurrence.
Journal ArticleDOI
Computer-Aided Diagnosis with Deep Learning Architecture: Applications to Breast Lesions in US Images and Pulmonary Nodules in CT Scans
Jie-Zhi Cheng,Dong Ni,Yi-Hong Chou,Jing Qin,Chui Mei Tiu,Yeun-Chung Chang,Chiun-Sheng Huang,Dinggang Shen,Chung-Ming Chen +8 more
TL;DR: The experimental results show the significant performance boost by the SDAE-based CADx algorithm over the two conventional methods, suggesting that deep learning techniques can potentially change the design paradigm of the CADx systems without the need of explicit design and selection of problem-oriented features.
Journal ArticleDOI
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
Evandro de Azambuja,Andrew P. Holmes,Martine Piccart-Gebhart,Eileen Holmes,Serena Di Cosimo,Ramona F. Swaby,Michael Untch,Christian Jackisch,István Láng,Ian E. Smith,Frances M. Boyle,Binghe Xu,Carlos H. Barrios,Edith A. Perez,Hatem A. Azim,Sung Bae Kim,Sherko Kuemmel,Chiun-Sheng Huang,Peter Vuylsteke,Ruey Kuen Hsieh,Vera Gorbunova,Alexandru Eniu,Lydia Dreosti,Natalia Tavartkiladze,Richard D. Gelber,Holger Eidtmann,José Baselga +26 more
TL;DR: The NeoALTTO trial showed that 3-year event-free survival was significantly improved for women who achieved pathological complete response compared with those who did not, and the association between pathological complete responded and overall survival was assessed.
Journal ArticleDOI
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Sung Bae Kim,Rebecca Dent,Seock-Ah Im,Marc Espié,Sibel Blau,Antoinette R Tan,Steven J Isakoff,Mafalda Oliveira,Cristina Saura,Matthew Wongchenko,Amy V. Kapp,Wai Y. Chan,Stina M. Singel,Daniel J Maslyar,José Baselga,Keun Seok Lee,Hwei Chung Wang,Antoinette R. Tan,Joohyuk Sohn,Michelino De Laurentiis,Laura G. Estévez,Chiun-Sheng Huang,Gilles Romieu,Michel Velez,Rafael Villanueva,Pierfranco Conte,Shaker R. Dakhil,Marc Debled,Antonio Gonzalez Martin,Sara A. Hurvitz,Jee Hyun Kim,Christelle Levy,Pedro Sánchez Rovira,Jae Hong Seo,Vicente Valero,Gregory Vidal,Andrea Wong,Mary Ann K Allison,Robert A. Figlin,David Chan,Shin-Cheh Chen,Yen-Hsun Chen,Melody A. Cobleigh,Filippo de Braud,Luc Dirix,Vincent Hansen,Anne Hardy Bessard,Nicholas Iannotti,Steven J. Isakoff,William E. Lawler,Alvaro Montaño,Mohamad Salkini,Leonard Seigel +52 more
TL;DR: These are the first results supporting AKT-targeted therapy for triple-negative breast cancer and Ipatasertib warrants further investigation for the treatment of triple- negative breast cancer.
Journal Article
Breast Cancer Risk Associated with Genotype Polymorphism of the Estrogen-metabolizing Genes CYP17, CYP1A1, and COMT A Multigenic Study on Cancer Susceptibility
TL;DR: On the basis of comprehensive profiles of estrogen metabolism, this study supports the possibility that breast cancer can be initiated by estrogen exposure.